First Manhattan’s RESPONSE GENETICS, INC COMMON SHS (DELAWARE) RGDX Stock Holding History

First Manhattan’s Portfolio RGDX Stock Details RGDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-45,496	Closed	-$14K	–	1546
2015 Q2	$14K	Hold	45,496	–	–	﹤0.01%	1158
2015 Q1	$20K	Hold	45,496	–	–	﹤0.01%	1125
2014 Q4	$14K	Hold	45,496	–	–	﹤0.01%	1186
2014 Q3	$31K	Hold	45,496	–	–	﹤0.01%	1048
2014 Q2	$41K	Sell	45,496 -45,000	-50%	-$47.1K	﹤0.01%	996
2014 Q1	$107K	Hold	90,496	–	–	﹤0.01%	793
2013 Q4	$104K	Hold	90,496	–	–	﹤0.01%	793
2013 Q3	$200K	Hold	90,496	–	–	﹤0.01%	665
2013 Q2	$186K	Buy	+90,496	New	+$123K	﹤0.01%	676

First Manhattan's RGDX Position: Q3 2015 in Review

First Manhattan sold out of RESPONSE GENETICS, INC COMMON SHS (DELAWARE) (RGDX) in Q3 2015, closing a stake of 45,496 shares — an estimated $14K sold.

First Manhattan first reported a position in RGDX in Q2 2013 and held it in 9 quarters. The position peaked at $200K in Q3 2013. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.

First Manhattan reported no remaining RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position as of Q3 2015 after selling out during the quarter.
First Manhattan sold 45,496 RESPONSE GENETICS, INC COMMON SHS (DELAWARE) shares in Q3 2015, an estimated $14K.
First Manhattan first reported a position in RESPONSE GENETICS, INC COMMON SHS (DELAWARE) in Q2 2013 and held it in 9 quarters.
First Manhattan's RESPONSE GENETICS, INC COMMON SHS (DELAWARE) position peaked at $200K in Q3 2013.
1 fund tracked by Wall St. Rank held RESPONSE GENETICS, INC COMMON SHS (DELAWARE) as of Q3 2015.

Based on First Manhattan's 13F filing for Q3 2015, filed 26 Oct 2015.